Share Price and Basic Stock Data
Last Updated: November 14, 2025, 10:40 pm
| PEG Ratio | 1.11 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Vadilal Industries Ltd operates within the Milk & Milk Products sector, where it has demonstrated significant growth over recent years. The company’s sales increased from ₹698 Cr in March 2022 to ₹1,058 Cr in March 2023, reflecting a robust growth trajectory of approximately 51.7%. For the financial year ending March 2025, sales are reported to rise further to ₹1,238 Cr, indicating a consistent upward trend. Quarterly sales data also illustrates this growth, with June 2023 sales reported at ₹411 Cr and June 2024 at ₹464 Cr, showcasing a solid recovery post-pandemic. This growth is underpinned by strategic product expansion and increased market penetration, which have enabled the company to capitalize on rising consumer demand for dairy products. However, the revenue growth must be viewed alongside the company’s expense trends, which rose to ₹999 Cr for the same period, indicating that while sales have risen, cost management remains crucial for sustaining profitability.
Profitability and Efficiency Metrics
Vadilal Industries has reported commendable profitability metrics, with a net profit of ₹150 Cr for the financial year ending March 2025, up from ₹96 Cr in March 2023. This growth led to an impressive net profit margin of 12.14% for March 2025, compared to 9.10% in March 2023, highlighting improved operational efficiency. The operating profit margin (OPM) stood at 19% for March 2025, slightly declining from 20% the previous year, indicating that while profitability remains strong, there may be pressure on margins due to rising costs. The company’s Return on Equity (ROE) was reported at 24.24%, showcasing effective utilization of shareholder funds. Furthermore, the interest coverage ratio (ICR) of 18.68x indicates that the company’s earnings are more than sufficient to cover interest expenses, reflecting financial stability. The cash conversion cycle, which increased to 143 days, signals potential challenges in managing working capital, necessitating further scrutiny of inventory and receivable management.
Balance Sheet Strength and Financial Ratios
Vadilal Industries’ balance sheet reflects a strong financial position, with total assets reported at ₹1,094 Cr as of March 2025, supported by reserves of ₹688 Cr. The company has maintained conservative leverage, with total borrowings at ₹218 Cr, resulting in a debt-to-equity ratio of 0.13, which is significantly lower than typical industry norms. This low leverage indicates a lower financial risk and an ability to withstand economic downturns. Additionally, the company’s current ratio of 2.56 and quick ratio of 1.06 suggest strong liquidity, allowing it to meet short-term obligations comfortably. The price-to-book value ratio stood at 5.33x, indicating market confidence in the company’s growth prospects. However, the company’s cash flow management should be closely monitored, especially with a cash earnings retention ratio of 99.44%, which while high, indicates that most earnings are being retained rather than distributed, possibly impacting short-term liquidity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vadilal Industries reveals significant promoter confidence, with promoters holding 64.72% of the total shares. This stable ownership structure suggests that the management is committed to the long-term vision of the company. Institutional investor participation remains minimal, with Foreign Institutional Investors (FIIs) holding 0.68% and Domestic Institutional Investors (DIIs) at 0.44% as of March 2025. The public shareholding stands at 34.23%, indicating a moderate level of retail investor interest. The increase in the number of shareholders from 12,487 in December 2022 to 19,638 in March 2025 reflects growing investor confidence, potentially driven by the company’s strong financial performance and growth prospects. However, the low institutional ownership could pose risks regarding liquidity and market perception, as institutional investors often provide stability to share prices during market fluctuations.
Outlook, Risks, and Final Insight
Looking ahead, Vadilal Industries is well-positioned for continued growth, driven by rising consumer demand for dairy products and strategic expansion initiatives. The company’s financial health, characterized by strong profitability and a robust balance sheet, supports its growth ambitions. However, potential risks include increasing raw material costs, which could pressure profit margins, and the management of working capital, as indicated by the rising cash conversion cycle. Additionally, the limited institutional investor presence could lead to volatility in share price movements. To mitigate these risks, the company may need to enhance its operational efficiency and explore avenues for cost control. Overall, with a solid foundation and growth trajectory, Vadilal Industries presents a compelling investment opportunity, provided it navigates the outlined challenges effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vadilal Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Dairies Ltd | 105 Cr. | 41.0 | 74.0/38.2 | 4.55 | 17.0 | 0.00 % | % | % | 10.0 |
| Healthy Life Agritec Ltd | 74.4 Cr. | 15.0 | 61.2/13.8 | 21.8 | 6.93 | 0.00 % | 13.3 % | 10.6 % | 10.0 |
| Dodla Dairy Ltd | 7,255 Cr. | 1,205 | 1,525/962 | 27.9 | 254 | 0.41 % | 26.6 % | 19.8 % | 10.0 |
| Vadilal Industries Ltd | 3,679 Cr. | 5,117 | 7,399/3,411 | 27.4 | 1,092 | 0.41 % | 25.1 % | 24.0 % | 10.0 |
| Umang Dairies Ltd | 189 Cr. | 85.7 | 128/67.0 | 309 | 20.7 | 0.00 % | 4.52 % | 1.35 % | 5.00 |
| Industry Average | 6,689.33 Cr | 1,148.24 | 69.25 | 226.59 | 0.27% | 17.99% | 15.49% | 7.29 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 391 | 267 | 143 | 256 | 411 | 289 | 174 | 251 | 464 | 296 | 204 | 274 | 506 |
| Expenses | 316 | 223 | 149 | 208 | 307 | 230 | 163 | 206 | 351 | 235 | 178 | 236 | 406 |
| Operating Profit | 75 | 44 | -6 | 49 | 104 | 59 | 11 | 46 | 113 | 61 | 26 | 39 | 100 |
| OPM % | 19% | 17% | -4% | 19% | 25% | 20% | 6% | 18% | 24% | 20% | 13% | 14% | 20% |
| Other Income | 4 | 4 | 4 | 2 | 2 | 4 | 4 | 3 | 4 | 5 | 4 | 3 | 5 |
| Interest | 5 | 3 | 4 | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 |
| Depreciation | 7 | 8 | 6 | 8 | 9 | 9 | 8 | 9 | 11 | 11 | 10 | 11 | 12 |
| Profit before tax | 67 | 37 | -12 | 38 | 92 | 50 | 3 | 35 | 103 | 52 | 17 | 27 | 89 |
| Tax % | 26% | 27% | -22% | 24% | 23% | 24% | -210% | 21% | 25% | 25% | 31% | 19% | 25% |
| Net Profit | 49 | 27 | -9 | 29 | 71 | 38 | 9 | 28 | 77 | 39 | 12 | 22 | 67 |
| EPS in Rs | 68.81 | 38.02 | -12.92 | 40.04 | 98.81 | 52.94 | 12.86 | 38.45 | 107.71 | 54.23 | 16.60 | 30.61 | 93.19 |
Last Updated: August 20, 2025, 1:40 am
Below is a detailed analysis of the quarterly data for Vadilal Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 506.00 Cr.. The value appears strong and on an upward trend. It has increased from 274.00 Cr. (Mar 2025) to 506.00 Cr., marking an increase of 232.00 Cr..
- For Expenses, as of Jun 2025, the value is 406.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 236.00 Cr. (Mar 2025) to 406.00 Cr., marking an increase of 170.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 61.00 Cr..
- For OPM %, as of Jun 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Mar 2025) to 20.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 62.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 25.00%, marking an increase of 6.00%.
- For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 45.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 93.19. The value appears strong and on an upward trend. It has increased from 30.61 (Mar 2025) to 93.19, marking an increase of 62.58.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:12 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 367 | 406 | 450 | 482 | 547 | 567 | 599 | 463 | 698 | 1,058 | 1,125 | 1,238 | 1,326 |
| Expenses | 327 | 367 | 391 | 425 | 499 | 494 | 521 | 428 | 599 | 892 | 904 | 999 | 1,110 |
| Operating Profit | 40 | 39 | 58 | 57 | 48 | 73 | 79 | 36 | 99 | 166 | 221 | 239 | 215 |
| OPM % | 11% | 10% | 13% | 12% | 9% | 13% | 13% | 8% | 14% | 16% | 20% | 19% | 16% |
| Other Income | 2 | 3 | 1 | 3 | 6 | 10 | 10 | 16 | 8 | 10 | 12 | 17 | 20 |
| Interest | 25 | 26 | 21 | 16 | 15 | 14 | 17 | 21 | 19 | 16 | 18 | 14 | 15 |
| Depreciation | 13 | 13 | 14 | 15 | 16 | 17 | 24 | 23 | 24 | 30 | 35 | 42 | 44 |
| Profit before tax | 4 | 4 | 24 | 29 | 23 | 52 | 48 | 8 | 64 | 131 | 180 | 200 | 177 |
| Tax % | 36% | 36% | 40% | 35% | 32% | 36% | 14% | 40% | 30% | 26% | 19% | 25% | |
| Net Profit | 2 | 2 | 15 | 19 | 16 | 33 | 41 | 5 | 45 | 96 | 146 | 150 | 134 |
| EPS in Rs | 3.20 | 3.39 | 20.53 | 26.52 | 21.79 | 46.41 | 57.57 | 6.44 | 62.19 | 133.96 | 203.05 | 209.15 | 186.90 |
| Dividend Payout % | 31% | 29% | 6% | 5% | 6% | 3% | 0% | 0% | 2% | 1% | 1% | 10% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 650.00% | 26.67% | -15.79% | 106.25% | 24.24% | -87.80% | 800.00% | 113.33% | 52.08% | 2.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | 650.00% | -623.33% | -42.46% | 122.04% | -82.01% | -112.05% | 887.80% | -686.67% | -61.25% | -49.34% |
Vadilal Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 21% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 30% |
| 3 Years: | 50% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 46% |
| 3 Years: | 25% |
| 1 Year: | 18% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 27% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 1:50 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 14 | 18 | 8 | 28 | 20 | 27 | 36 | 34 | 27 | 31 | 36 |
| Inventory Days | 178 | 144 | 138 | 135 | 119 | 157 | 179 | 211 | 170 | 167 | 146 | 188 |
| Days Payable | 104 | 96 | 104 | 92 | 91 | 86 | 98 | 165 | 85 | 58 | 62 | 81 |
| Cash Conversion Cycle | 89 | 62 | 51 | 51 | 56 | 91 | 107 | 81 | 119 | 135 | 115 | 143 |
| Working Capital Days | -40 | -49 | -40 | -37 | -4 | -5 | -14 | -20 | 17 | 29 | 50 | 78 |
| ROCE % | 10% | 10% | 18% | 17% | 13% | 20% | 17% | 7% | 19% | 26% | 27% | 25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 209.15 | 203.05 | 133.97 | 62.19 | 6.44 |
| Diluted EPS (Rs.) | 209.15 | 203.05 | 133.97 | 62.19 | 6.44 |
| Cash EPS (Rs.) | 267.77 | 251.54 | 175.54 | 95.54 | 38.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 862.41 | 650.05 | 448.45 | 309.43 | 245.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 967.05 | 754.70 | 553.13 | 414.11 | 349.74 |
| Revenue From Operations / Share (Rs.) | 1721.95 | 1565.13 | 1471.74 | 970.70 | 645.25 |
| PBDIT / Share (Rs.) | 355.45 | 323.74 | 245.27 | 149.13 | 72.31 |
| PBIT / Share (Rs.) | 296.76 | 275.19 | 203.70 | 115.77 | 40.52 |
| PBT / Share (Rs.) | 277.73 | 250.29 | 181.64 | 88.80 | 10.69 |
| Net Profit / Share (Rs.) | 209.08 | 202.99 | 133.97 | 62.19 | 6.44 |
| NP After MI And SOA / Share (Rs.) | 209.08 | 202.99 | 133.97 | 62.19 | 6.44 |
| PBDIT Margin (%) | 20.64 | 20.68 | 16.66 | 15.36 | 11.20 |
| PBIT Margin (%) | 17.23 | 17.58 | 13.84 | 11.92 | 6.27 |
| PBT Margin (%) | 16.12 | 15.99 | 12.34 | 9.14 | 1.65 |
| Net Profit Margin (%) | 12.14 | 12.96 | 9.10 | 6.40 | 0.99 |
| NP After MI And SOA Margin (%) | 12.14 | 12.96 | 9.10 | 6.40 | 0.99 |
| Return on Networth / Equity (%) | 24.24 | 31.24 | 29.90 | 20.12 | 2.63 |
| Return on Capital Employeed (%) | 24.01 | 28.15 | 26.02 | 20.52 | 8.69 |
| Return On Assets (%) | 13.71 | 15.91 | 11.49 | 7.17 | 0.81 |
| Long Term Debt / Equity (X) | 0.07 | 0.08 | 0.18 | 0.34 | 0.32 |
| Total Debt / Equity (X) | 0.13 | 0.25 | 0.63 | 0.77 | 0.72 |
| Asset Turnover Ratio (%) | 1.23 | 1.28 | 1.45 | 1.01 | 0.66 |
| Current Ratio (X) | 2.56 | 2.02 | 1.44 | 1.39 | 1.04 |
| Quick Ratio (X) | 1.06 | 0.95 | 0.51 | 0.63 | 0.43 |
| Inventory Turnover Ratio (X) | 4.59 | 2.05 | 2.51 | 2.33 | 1.52 |
| Dividend Payout Ratio (NP) (%) | 0.71 | 0.73 | 0.93 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.56 | 0.59 | 0.71 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 99.29 | 99.27 | 99.07 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 99.44 | 99.41 | 99.29 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 18.68 | 13.00 | 11.12 | 5.53 | 2.42 |
| Interest Coverage Ratio (Post Tax) (X) | 11.99 | 9.15 | 7.07 | 3.31 | 1.22 |
| Enterprise Value (Cr.) | 3345.68 | 3189.08 | 1750.95 | 1137.24 | 737.41 |
| EV / Net Operating Revenue (X) | 2.70 | 2.83 | 1.66 | 1.63 | 1.59 |
| EV / EBITDA (X) | 13.09 | 13.70 | 9.93 | 10.61 | 14.19 |
| MarketCap / Net Operating Revenue (X) | 2.67 | 2.78 | 1.50 | 1.46 | 1.39 |
| Retention Ratios (%) | 99.28 | 99.26 | 99.06 | 0.00 | 0.00 |
| Price / BV (X) | 5.33 | 6.69 | 4.92 | 4.58 | 3.67 |
| Price / Net Operating Revenue (X) | 2.67 | 2.78 | 1.50 | 1.46 | 1.39 |
| EarningsYield | 0.04 | 0.04 | 0.06 | 0.04 | 0.01 |
After reviewing the key financial ratios for Vadilal Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 209.15. This value is within the healthy range. It has increased from 203.05 (Mar 24) to 209.15, marking an increase of 6.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 209.15. This value is within the healthy range. It has increased from 203.05 (Mar 24) to 209.15, marking an increase of 6.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 267.77. This value is within the healthy range. It has increased from 251.54 (Mar 24) to 267.77, marking an increase of 16.23.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 862.41. It has increased from 650.05 (Mar 24) to 862.41, marking an increase of 212.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 967.05. It has increased from 754.70 (Mar 24) to 967.05, marking an increase of 212.35.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,721.95. It has increased from 1,565.13 (Mar 24) to 1,721.95, marking an increase of 156.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 355.45. This value is within the healthy range. It has increased from 323.74 (Mar 24) to 355.45, marking an increase of 31.71.
- For PBIT / Share (Rs.), as of Mar 25, the value is 296.76. This value is within the healthy range. It has increased from 275.19 (Mar 24) to 296.76, marking an increase of 21.57.
- For PBT / Share (Rs.), as of Mar 25, the value is 277.73. This value is within the healthy range. It has increased from 250.29 (Mar 24) to 277.73, marking an increase of 27.44.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 209.08. This value is within the healthy range. It has increased from 202.99 (Mar 24) to 209.08, marking an increase of 6.09.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 209.08. This value is within the healthy range. It has increased from 202.99 (Mar 24) to 209.08, marking an increase of 6.09.
- For PBDIT Margin (%), as of Mar 25, the value is 20.64. This value is within the healthy range. It has decreased from 20.68 (Mar 24) to 20.64, marking a decrease of 0.04.
- For PBIT Margin (%), as of Mar 25, the value is 17.23. This value is within the healthy range. It has decreased from 17.58 (Mar 24) to 17.23, marking a decrease of 0.35.
- For PBT Margin (%), as of Mar 25, the value is 16.12. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 16.12, marking an increase of 0.13.
- For Net Profit Margin (%), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 10. It has decreased from 12.96 (Mar 24) to 12.14, marking a decrease of 0.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.14. This value is within the healthy range. It has decreased from 12.96 (Mar 24) to 12.14, marking a decrease of 0.82.
- For Return on Networth / Equity (%), as of Mar 25, the value is 24.24. This value is within the healthy range. It has decreased from 31.24 (Mar 24) to 24.24, marking a decrease of 7.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.01. This value is within the healthy range. It has decreased from 28.15 (Mar 24) to 24.01, marking a decrease of 4.14.
- For Return On Assets (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has decreased from 15.91 (Mar 24) to 13.71, marking a decrease of 2.20.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.13, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.23. It has decreased from 1.28 (Mar 24) to 1.23, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 2.56. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 2.56, marking an increase of 0.54.
- For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 1.06, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.59. This value is within the healthy range. It has increased from 2.05 (Mar 24) to 4.59, marking an increase of 2.54.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 20. It has decreased from 0.73 (Mar 24) to 0.71, marking a decrease of 0.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 20. It has decreased from 0.59 (Mar 24) to 0.56, marking a decrease of 0.03.
- For Earning Retention Ratio (%), as of Mar 25, the value is 99.29. This value exceeds the healthy maximum of 70. It has increased from 99.27 (Mar 24) to 99.29, marking an increase of 0.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.44. This value exceeds the healthy maximum of 70. It has increased from 99.41 (Mar 24) to 99.44, marking an increase of 0.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 13.00 (Mar 24) to 18.68, marking an increase of 5.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.99. This value is within the healthy range. It has increased from 9.15 (Mar 24) to 11.99, marking an increase of 2.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,345.68. It has increased from 3,189.08 (Mar 24) to 3,345.68, marking an increase of 156.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.70. This value is within the healthy range. It has decreased from 2.83 (Mar 24) to 2.70, marking a decrease of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 13.09. This value is within the healthy range. It has decreased from 13.70 (Mar 24) to 13.09, marking a decrease of 0.61.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.78 (Mar 24) to 2.67, marking a decrease of 0.11.
- For Retention Ratios (%), as of Mar 25, the value is 99.28. This value exceeds the healthy maximum of 70. It has increased from 99.26 (Mar 24) to 99.28, marking an increase of 0.02.
- For Price / BV (X), as of Mar 25, the value is 5.33. This value exceeds the healthy maximum of 3. It has decreased from 6.69 (Mar 24) to 5.33, marking a decrease of 1.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.78 (Mar 24) to 2.67, marking a decrease of 0.11.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vadilal Industries Ltd:
- Net Profit Margin: 12.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.01% (Industry Average ROCE: 17.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.24% (Industry Average ROE: 15.49%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.99
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.4 (Industry average Stock P/E: 69.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.13
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Milk & Milk Products | Vadilal House, Shrimali Society, Nr. Navrangpura Rly. Crossing, Ahmedabad Gujarat 380009 | info@vadilalgroup.com http://www.vadilalgroup.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shivakumar Dega | Chairman & Ind.Director |
| Mr. Janmajay V Gandhi | Executive Director |
| Mr. Shalini Raghavan | Independent Director |
| Mrs. Gaurav Marathe | Non Exe.Non Ind.Director |
| Mr. Nagarajan Sivaramakrishnan | Independent Director |